Retatrutide is a new experimental peptide, and many people are concerned about the side effects and long-term safety of Retatrutide compared to the approved peptides Semaglutide and Tirzepetide. Today we discuss the worst possible side effects of Retatrutide. Retatrutide is a triple receptor agonist that acts on GLP-1R, GIPR and GCGR simultaneously, while Semaglutide acts on GLP-1R and Tirzpetide acts …